Savvy Advisors Inc’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54M Sell
63,860
-474
-0.7% -$12.4K 0.03% 393
2026
Q1
$1.81M Buy
64,334
+11,165
+21% +$297K 0.05% 289
2025
Q4
$1.32M Buy
53,169
+23,015
+76% +$580K 0.04% 315
2025
Q3
$768K Buy
30,154
+2,223
+8% +$54.9K 0.04% 321
2025
Q2
$677K Buy
27,931
+2,906
+12% +$67.8K 0.05% 292
2025
Q1
$634K Sell
25,025
-1,399
-5% -$36.6K 0.06% 243
2024
Q4
$701K Buy
26,424
+2,085
+9% +$56.6K 0.08% 193
2024
Q3
$704K Buy
24,339
+3,058
+14% +$89.2K 0.14% 144
2024
Q2
$595K Buy
21,281
+1,838
+9% +$50.6K 0.19% 120
2024
Q1
$540K Buy
19,443
+93
+0.5% +$2.58K 0.31% 82
2023
Q4
$557K Buy
+19,350
New +$585K 0.54% 51

Other funds holding PFE

Savvy Advisors Inc's PFE Position: Q2 2026 in Review

Savvy Advisors Inc reduced its Pfizer (PFE) stake by 0.74% in Q2 2026, selling an estimated $12.4K and leaving 63,860 shares worth $1.54M. The position accounts for 0.03% of the portfolio, ranked #393.

Savvy Advisors Inc first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.81M in Q1 2026. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Savvy Advisors Inc held 63,860 shares of Pfizer worth $1.54M as of Q2 2026.
  • Savvy Advisors Inc sold 474 Pfizer shares in Q2 2026, an estimated $12.4K.
  • Pfizer made up 0.03% of Savvy Advisors Inc's portfolio in Q2 2026, its #393 holding.
  • Savvy Advisors Inc first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Savvy Advisors Inc's Pfizer position peaked at $1.81M in Q1 2026.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Savvy Advisors Inc's 13F filing for Q2 2026, filed 3 Aug 2026.